Functional genomics and assays of regulatory activity detect mechanisms at loci for lipid traits and coronary artery disease

Current Opinion in Genetics & Development
Tamara S Roman, Karen L Mohlke

Abstract

Many genome-wide association studies (GWAS) have identified signals located in non-coding regions, and an increasing number of functional genomics annotations of regulatory elements and assays of regulatory activity have been used to investigate mechanisms. Genome-wide datasets that characterize chromatin structure help detect potential regulatory elements. Assays to experimentally assess candidate variants include transcriptional reporter assays, and recently, massively parallel reporter assays (MPRAs). Additionally, the effect of candidate regulatory elements and variants on gene expression and function can be evaluated using genomic editing with the CRISPR-Cas9 technology. We highlight some recent studies that employed these strategies to identify variant effects and elucidate molecular and/or biological mechanisms at GWAS loci for lipid traits and coronary artery disease.

References

May 29, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lucia A HindorffTeri A Manolio
Nov 6, 2009·Nature·Melissa J FullwoodYijun Ruan
Nov 17, 2009·Nature Biotechnology·Rupali P PatwardhanJay Shendure
May 13, 2010·Journal of Visualized Experiments : JoVE·Nynke L van BerkumEric S Lander
Oct 15, 2010·The New England Journal of Medicine·Kiran MusunuruSekar Kathiresan
Dec 17, 2010·Nature·Alvaro Rada-IglesiasJoanna Wysocka
May 11, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Katherine E HankowskiNaohiro Terada
Oct 5, 2011·Current Cardiology Reports·Beatriz G Talayero, Frank M Sacks
Mar 1, 2012·Nature Biotechnology·Rupali P PatwardhanJay Shendure
Mar 1, 2012·Nature Methods·Jason Ernst, Manolis Kellis
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Nov 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jamie C KwasnieskiBarak A Cohen
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Jan 19, 2013·Science·Cosmas D ArnoldAlexander Stark
May 6, 2015·Nature Genetics·Borbala MifsudCameron S Osborne
Dec 8, 2015·American Journal of Human Genetics·Tamara S RomanKaren L Mohlke
Nov 22, 2016·American Journal of Human Genetics·Jiangchuan YePatrick T Ellinor
Mar 3, 2017·Wiley Interdisciplinary Reviews. Developmental Biology·Rafael D AcemelJosé Luis Gómez-Skarmeta
Apr 5, 2017·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Eric DannerRalf Kühn
May 11, 2017·Circulation·Thorsten KesslerHeribert Schunkert
Jun 16, 2017·Nature·Teri A Manolio
Jul 8, 2017·American Journal of Human Genetics·Peter M VisscherJian Yang
Jul 30, 2017·G3 : Genes - Genomes - Genetics·Maren E CannonKaren L Mohlke

❮ Previous
Next ❯

Citations

Nov 6, 2018·Expert Review of Proteomics·Dario Aspesi, Graziano Pinna

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance (ASM)

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

© 2022 Meta ULC. All rights reserved